跳至主要内容
临床试验/JPRN-UMIN000007427
JPRN-UMIN000007427招募中未知

A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma. - A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.

Division of Gastroenterology, Department of Medicine Kurume University School of Medicine0 个研究点目标入组 300 人开始时间: 2012年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • An infectious disease of the activity (but except the viral hepatitis) An overlap cancer of the activity A past of sensitivity to iodocontrast media A pregnant woman, a nursing girl may be pregnant The case that the medical attendant judged to be inappropriate as an object of the final examination for reasons of others (problem cases such as a patient does not hear instructions or the support of the family not being provided)

研究者

发起方
Division of Gastroenterology, Department of Medicine Kurume University School of Medicine

相似试验